Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27134415 | 0.85 | RAB9A (0.44) | TSHRHSD17B10ALDH1A1KDM4EKMT2A | |
| SCHEMBL24072387 | 0.84 | KDM4E (0.44) | TSHRHSD17B10ALDH1A1KDM4EKMT2A | |
| SCHEMBL27134412 | 0.83 | CCNE1 (0.44) | TSHRHSD17B10ALDH1A1KDM4EKMT2A | |
| SCHEMBL24072390 | 0.82 | JAK2 (0.47) | TSHRHSD17B10ALDH1A1KDM4EKMT2A | |
| SCHEMBL24073682 | 0.82 | ALDH1A1 (0.44) | TSHRHSD17B10ALDH1A1KDM4EKMT2A | |
| SCHEMBL24073675 | 0.82 | KDM4E (0.43) | TSHRHSD17B10ALDH1A1KDM4EKMT2A | |
| SCHEMBL24073667 | 0.81 | CCNE1 (0.44) | ALDH1A1KDM4EKMT2AMEN1HTT | |
| SCHEMBL24072309 | 0.81 | MEN1 (0.49) | ALDH1A1KDM4EKMT2AMEN1POLB | |
| SCHEMBL24073673 | 0.81 | KDM4E (0.58) | TSHRALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL24074429 | 0.80 | RAB9A (0.52) | ALDH1A1KDM4EHPGDHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066136-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | CULLGEN (SHANGHAI), INC. (CN) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066136-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | DDB1, DCLRE1A, MDM2 | TSHR 3370/4885HSD17B10 2241/4885ALDH1A1 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.